Paper25751641
Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.
Zhang X and 6 others. Hum Vaccin Immunother, 2015. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins. Papers, record 25751641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25751641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Capsid Proteins | Major topic |
| Epitopes | Major topic |
| Papillomavirus Vaccines | Major topic |
| Vaccines, Virus-Like Particle | Major topic |
| Viral Hepatitis Vaccines | Major topic |
| Drug Discovery | |
| Humans | |
| Technology, Pharmaceutical | |
| Vaccines, Synthetic |
Source PubMed
References157
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8046412 | Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. | J Gen Virol | 1994 | https://conductscience.org/library/papers/8046412 | PubMed |
| 2 | 23281113 | Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts. | Protein Sci | 2013 | https://conductscience.org/library/papers/23281113 | PubMed |
| 3 | 20598725 | Study of infectious virus production from HPV18/16 capsid chimeras. | Virology | 2010 | https://conductscience.org/library/papers/20598725 | PubMed |
| 4 | 10233949 | Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. | J Virol | 1999 | https://conductscience.org/library/papers/10233949 | PubMed |
| 5 | 20139221 | Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. | J Natl Cancer Inst | 2010 | https://conductscience.org/library/papers/20139221 | PubMed |
| 6 | 19374929 | Influenza vaccines based on virus-like particles. | Virus Res | 2009 | https://conductscience.org/library/papers/19374929 | PubMed |
| 7 | 22356831 | Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. | Virol J | 2012 | https://conductscience.org/library/papers/22356831 | PubMed |
| 8 | 2997616 | Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. | Nature | 1985 | https://conductscience.org/library/papers/2997616 | PubMed |
| 9 | 9680478 | Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. | J Mol Biol | 1998 | https://conductscience.org/library/papers/9680478 | PubMed |
| 10 | 10639310 | HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain. | Virology | 2000 | https://conductscience.org/library/papers/10639310 | PubMed |
| 11 | 11738749 | Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. | Vaccine | 2001 | https://conductscience.org/library/papers/11738749 | PubMed |
| 12 | 17403562 | Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. | Vaccine | 2007 | https://conductscience.org/library/papers/17403562 | PubMed |
| 13 | 2170694 | Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. | J Virol | 1990 | https://conductscience.org/library/papers/2170694 | PubMed |
| 14 | 8392600 | Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. | J Virol | 1993 | https://conductscience.org/library/papers/8392600 | PubMed |
| 15 | 11878901 | Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. | Virology | 2001 | https://conductscience.org/library/papers/11878901 | PubMed |
| 16 | 16310896 | Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine. | Vaccine | 2006 | https://conductscience.org/library/papers/16310896 | PubMed |
| 17 | 20420879 | Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy. | Biochimie | 2010 | https://conductscience.org/library/papers/20420879 | PubMed |
| 18 | 17329696 | Safety and efficacy of a recombinant hepatitis E vaccine. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17329696 | PubMed |
| 19 | 22144891 | Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/22144891 | PubMed |
| 20 | 15780738 | A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. | Vaccine | 2005 | https://conductscience.org/library/papers/15780738 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42112438 | Engineering strategies and decision frameworks for virus-like particle-based vaccines against infectious diseases. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42112438 | PubMed |
| 42012184 | Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. | J Virol | 2026 | https://conductscience.org/library/papers/42012184 | PubMed |
| 41691583 | Immune Responses to Human Papillomavirus After Infection and Vaccination. | Curr Top Microbiol Immunol | 2026 | https://conductscience.org/library/papers/41691583 | PubMed |
| 40240438 | Discovery of novel HBV core protein inhibitors by high throughput virtual screening. | Sci Rep | 2025 | https://conductscience.org/library/papers/40240438 | PubMed |
| 39772006 | Protein Expression Platforms and the Challenges of Viral Antigen Production. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39772006 | PubMed |
| 37629147 | Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37629147 | PubMed |
| 37441076 | Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirus. | Front Immunol | 2023 | https://conductscience.org/library/papers/37441076 | PubMed |
| 32880435 | Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape. | Biomacromolecules | 2020 | https://conductscience.org/library/papers/32880435 | PubMed |
| 32349216 | Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines. | Viruses | 2020 | https://conductscience.org/library/papers/32349216 | PubMed |
| 32131431 | Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32131431 | PubMed |
| 31995442 | Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/31995442 | PubMed |
| 31963175 | Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation. | Viruses | 2020 | https://conductscience.org/library/papers/31963175 | PubMed |
| 31376116 | Recent trends and advances in microbe-based drug delivery systems. | Daru | 2019 | https://conductscience.org/library/papers/31376116 | PubMed |
| 30845175 | Efficient expression of enterovirus 71 based on virus-like particles vaccine. | PLoS One | 2019 | https://conductscience.org/library/papers/30845175 | PubMed |
| 30172637 | Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine. | Vaccine | 2018 | https://conductscience.org/library/papers/30172637 | PubMed |
| 29263864 | Escherichia coli-derived virus-like particles in vaccine development. | NPJ Vaccines | 2017 | https://conductscience.org/library/papers/29263864 | PubMed |
| 29137642 | Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli. | Microb Cell Fact | 2017 | https://conductscience.org/library/papers/29137642 | PubMed |
| 28902491 | Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing. | ACS Nano | 2017 | https://conductscience.org/library/papers/28902491 | PubMed |
| 28004837 | The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies. | Sci Rep | 2016 | https://conductscience.org/library/papers/28004837 | PubMed |
| 27184971 | Hepatitis E virus: Current epidemiology and vaccine. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27184971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25751641
GET https://conductscience.org/api/papers/v1/25751641/references?page=2